Nomura Asset Management’s Structure Therapeutics GPCR Stock Holding History

Nomura Asset Management’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.76M	Hold	32,790	–	–	﹤0.01%	718
2026 Q1	$1.58M	Buy	32,790 +3,638	+12%	+$249K	﹤0.01%	722
2025 Q4	$2.03M	Buy	29,152 +3,296	+13%	+$135K	0.01%	707
2025 Q3	$724K	Buy	25,856 +982	+4%	+$19.6K	﹤0.01%	773
2025 Q2	$516K	Sell	24,874 -4,100	-14%	-$90.2K	﹤0.01%	800
2025 Q1	$502K	Sell	28,974 -7,951	-22%	-$195K	﹤0.01%	812
2024 Q4	$1M	Buy	36,925 +7,496	+25%	+$266K	﹤0.01%	778
2024 Q3	$1.29M	Buy	29,429 +7,719	+36%	+$298K	﹤0.01%	769
2024 Q2	$853K	Buy	21,710 +3,933	+22%	+$161K	﹤0.01%	793
2024 Q1	$762K	Buy	+17,777	New	+$750K	﹤0.01%	806

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Jupiter Topco New York $245B AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nomura Asset Management's GPCR Position: Q2 2026 in Review

Nomura Asset Management held its Structure Therapeutics (GPCR) position steady in Q2 2026 at 32,790 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #718.

Nomura Asset Management first reported a position in GPCR in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.03M in Q4 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

Nomura Asset Management held 32,790 shares of Structure Therapeutics worth $1.76M as of Q2 2026.
Nomura Asset Management left its Structure Therapeutics share count unchanged in Q2 2026.
Structure Therapeutics made up ﹤0.01% of Nomura Asset Management's portfolio in Q2 2026, its #718 holding.
Nomura Asset Management first reported a position in Structure Therapeutics in Q1 2024 and has held it in 10 quarters since.
Nomura Asset Management's Structure Therapeutics position peaked at $2.03M in Q4 2025.
191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.